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Background: Data about prevalence of gastroesophageal reflux diseases (GERD) from Asian populations are still
scarce. To provide additional data on prevalence of GERD and investigate its potential risk factors, we performed
this cross-sectional study in the Taizhou Retiree Cohort.
Methods: After physical examination, the participants were asked whether they suffered with heartburn or acid
regurgitation in the last 12 months by trained interviewers, and if yes, the severity and frequency of the symptoms
were recorded. Odds ratios (ORs) with 95% confidence intervals (CIs) for the associations of obesity and other risk
factors with GERD were derived from logistic regression models.
Results: 8831 retirees completed the questionnaire and physical examination. In total 150 (1.7%) reported the
symptoms occurring at least once per week within the last 12 months before the interview. Compared with
subjects without GERD, having a history of diabetes mellitus (OR 2.2, 95% CI 1.4-3.5), hypertension (OR 1.4, 95% CI
1.0-2.1), gastritis (OR 8.2, 95% CI 5.8-11.5), peptic ulcer (OR 3.3, 95% CI 1.8-6.1) and high triglyceride level
(≥1.81mmol/L) (OR 2.0, 95% CI 1.2-3.4) were associated with a significantly increased risk of GERD. However, there
was no significant association between body mass index, waist-to-hip ratio or waist alone, smoking, consumption
of alcohol & tea, and the occurrence of reflux symptoms.
Conclusions: Compared with Western populations, the prevalence of GERD in this Chinese retiree cohort is low. A
history of diabetes mellitus, hypertension, gastritis, peptic ulcer or hypertriglyceridaemia increases GERD risk in this
population.
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Gastroesophageal reflux disease (GERD) is a chronic dis-
ease that is associated with a range of troublesome symp-
toms, which can in turn have a significant impact on
health-related quality of life. Western countries have experi-
enced GERD epidemic in recent decades; a systematic re-
view article concluded that the prevalence of GERD was
10-20% in Western countries [1]. Recently, the prevalence
of GERD has been reported to increase rapidly in Asia
[2-5]. However, studies on Asian populations are still scarce.
There is a widespread notion that obesity and abdominal
obesity may increase the risk of GERD, especially in* Correspondence: lvming@sdu.edu.cn
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reproduction in any medium, provided the orWestern populations [6-9]. High body mass index (BMI)
is associated with a dose-dependently increased risk for
GERD, erosive esophagitis, and esophageal adenocarcin-
oma. Several studies have reported that the adverse effect
of obesity on GERD is through mechanical alterations at
the esophagogastric junction [10,11]. However, since not
every obese patient develops GERD, the pathogenesis
must be multifactorial and cannot be explained by a single
physiological parameter. Additional observations demon-
strated the association between GERD and metabolic risk
factors including hypertension, hypertriglyceridaemia and
diabetes mellitus [12-14]. There is also suggestive relation-
ship between GERD and peptic ulcer and gastritis [15,16],
but the results are not consistent.
In this study, we therefore intended to investigate the
prevalence of gastroesophageal reflux symptoms and to
determine whether BMI, waist circumference, waist-to-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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toms in the Taizhou Retiree Cohort.
Methods
The study cohort and data collection
Taizhou Longitudinal Study phase II (retiree cohort) was
started from December of 2007, detailed description of
study methods has been published previously [17], Briefly,
all retirees who registered in the Social Insurance Bureau
of Hailing (a district of Taizhou city), were invited to
undergo a medical examination and their blood samples
were collected for testing serum lipid, glucose and other
biochemical profile. Information on demographic charac-
teristics, lifestyle, as well as history of major chronic dis-
eases was also collected for each participant. A simplified
questionnaire about gastroesophageal reflux symptoms
was added since September of 2008 and used till the end
of enrollment, August 2009 [18,19]. The trained inter-
viewers asked the participants whether or not they suf-
fered with heartburn or acid regurgitation in the past 12
months, and if yes, the frequency of the symptoms, and
the age the symptoms started. Heartburn and acid regurgi-
tation are the cardinal symptoms of gastroesophageal re-
flux disease, and the use of questionnaires to assess these
symptoms is well validated as a reliable measurement of
the true occurrence of reflux [20,21]. Symptom of “heart-
burn” was defined as “the burning sensation behind breast
bone”, and “acid regurgitation” was defined as “a bitter or
sour tasting fluid coming into the throat or chest”. Symp-
tom frequency was reported as: less than once per month,
once per month, once per week, 2-3 times per week, 3-4
times per week or daily. We also asked whether the symp-
toms affected subjects’ daily life including sleep, dietary
habits and physical activity. The influences of the of symp-
toms were reported as negligible, mild (almost can be
ignored), moderate (cannot be ignored but can be toler-
ated), severe (affects normal daily life) and very severe
(markedly, affects normal daily life). A summary severity
score was then created by taking max value of the influ-
ences, and grouping negligible and mild category together.
Participants were also asked whether they took medication
for their symptoms, such as H2-receptor antagonist
(H2Ra) or proton pump inhibitors (PPI).
Exposure assessment
Body weight, height, waist and hip circumference were
measured by trained staff. The waist circumference was
measured midway between the caudal point of the costal
arch as palpated laterally and the iliac crest. BMI (kg/m2)
was calculated as weight (kg) divided by square of height
(m). WHR was defined as waist divided by hip circumfer-
ence. Further, we categorized BMI into three groups,
<24.0, 24.0-27.9 and ≥28.0. Overweight was defined as
BMI between 24.0 and 27.9, and obesity was defined asBMI ≥28.0 according to the definition proposed by Work-
ing Group on Obesity in China [22].
Abdominal obesity was defined as women with a waist
of ≥ 88 cm or man with a waist of ≥ 92 cm (both were
upper quarter of waist accordingly). Women with a
WHR of ≥ 0.89 or man with a WHR of ≥ 0.95 were also
defined as central obesity.
Smoking status was categorized into three groups: ever
smoked but quit now, current smokers and never smo-
kers. Participants who reported an average frequency of
alcohol intake of over 4 times per month were regarded
as regular drinkers; tea drinkers were defined as at least
one cup per day.
Participants were also asked to report their history of
diseases (with diagnosis from a hospital), including dia-
betes mellitus, hypertension, cardiovascular and cerebro-
vascular diseases, tumor, asthma, gastritis, peptic ulcer,
hepatitis, tuberculosis and gallstone. Medications taken
by participants regularly were also recorded.
Statistical analysis
We defined GERD cases as ever experiencing symptoms of
heartburn and/or regurgitation at least once per week. The
control group comprised of those without reported GERD.
Odds ratios (ORs) with 95% confidence intervals (CIs)
for the association of potential risk factors with GERD
were derived from logistic regression models. All ana-
lyses were conducted using SAS version 9.1 (SAS Insti-
tute Inc, Cary, NC). Two-sided P values <0.05 were
considered statistically significant. The study was
approved by the Human Ethics Committee of Fudan
University. Written informed consent was obtained from
all participants.
Results
From August 2008 to the end of baseline enrollment
(Aug 2009), 8867 retirees aged 40 to 93 years completed
the questionnaire and physical examination. In the pro-
cedure of data cleaning, we deleted 36 records for in-
complete age, weight or height. Cohort demographic
characteristics are presented in Table 1. Among 8831
participants (with a mean age of 62.5±8.3 years), 64.9%
were females and females tended to have lower educa-
tion level (primary school or lower, female: 60.7% vs.
male: 41.4%), and more likely to be blue collar workers
(93.9% vs. 79.6%).
Among these 8831 participants, only 158 (1.8%)
reported ever having symptom of heartburn, 907 (10.3%)
reported ever having symptom of acid regurgitation.
Among all these symptomatic subjects, 499 (5.7%) had
reflux symptom less than once per month, 281 (3.2%)
reported once per month, 72 (0.8%) once per week, 55
(0.6%) several times per week, and 23 (0.3%) daily
(Table 1). For the age group 40-49, 50-59, 60-69, 70-79,
Table 1 Characteristics of the Taizhou Retiree Cohort
Male (n=3097) Female (n=5734)
Age (years, mean±SD) 66.48±6.91 60.36±7.61
BMI (mean±SD) 24.53±3.22 24.89±3.51
Waist (cm, mean±SD) 86.30±8.71 82.72±8.71
WHR (mean±SD) 0.91±0.06 0.85±0.05
SBP (mmHg, mean±SD) 141.4±19.7 138.9±20.3
DBP (mmHg, mean±SD) 88.3±12.1 83.3±11.5
Education (%)
Primary school or lower 1283 (41.4) 3478 (60.7)
Primary high school 1045 (33.8) 1535 (26.8)
Secondary high school 551 (17.8) 663 (11.6)
College and above 217 (7.0) 55 (0.9)
Occupation (%)
Blue collar 2463 (79.6) 5380 (93.9)
White collar 632 (20.4) 345 (6.1)
Smoking (%)
Ex-smokers 598 (19.3) 36 (0.6)
Current smokers 1475 (47.7) 293 (5.1)
Never 1019 (33.0) 5403 (94.3)
Alcohol drinking (%)
Yes 1208 (39.0) 97 (1.7)
No 1889 (61.0) 5637 (98.3)
Tea drinking (%)
Yes 1570 (50.7) 537 (9.4)
No 1526 (49.3) 5159 (90.6)
Frequency of gastroesophageal reflux symptoms
Never 2820 (91.1) 5081 (88.6)
Less than once per month 156 (5.0) 343 (6.0)
Once per month 71 (2.3) 210 (3.7)
Once per week 22 (0.7) 50 (0.9)
Several times per week 15 (0.5) 40 (0.7)
Daily 13 (0.4) 10 (0.2)
BMI: body mass index (weight[kg]/height2[m]); WHR: waist-to-hip ratio; SBP:
systolic blood pressure; DBP: diastolic blood pressure.
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8.8%, and 10.0%, respectively. For women, the prevalence
in each age group was: 12.4%, 11.2%, 11.9%, 10.8% and
9.9%. For men, the prevalence was: 14.8%, 14.8%, 8.3%,
7.2% and 10.2%, respectively.
For further analyses, we defined the 150 (1.7%) partici-
pants who reported the symptoms (either heartburn or
acid regurgitation) at least once a week as GERD cases.
Severity and frequency of the symptoms among the 150
cases and the medications they took are presented in
Table 2. We deleted 780 participants who reported having
the symptom once per month or less to avoid bias from
misclassification. The rest of 7901 (89.5%) participants,
who reported having neither heartburn nor acidregurgitation, as well as not taking any anti-acids, were
considered as controls.
Obesity related factors
Compared with subjects with normal weight, overweight
subjects (BMI 24.0-27.9 kg/m2) had a multivariable-
adjusted OR of 1.0 (95%CI 0.7-1.4) for developing the
symptoms and the corresponding OR was 0.7 (95%CI
0.4-1.2) for obese subjects (BMI ≥28.0 kg/m2) (Table 3).
Similarly, waist-to-hip ratio or waist alone did not show
any significant association with the symptoms (Table 3).
Lifestyle related factors
Smoking was not associated with any change in the risk
of GERD. There was also no significant association
between alcohol drinking, tea drinking and the occur-
rence of reflux symptoms (Table 4).
Past history of diseases
Subjects with self-reported diabetes mellitus were more
likely to have report the symptoms, with a multivariable-
adjusted OR of 2.2 (95% CI 1.4-3.5). Hypertension was
also strongly associated with the development of the
symptoms and the corresponding OR was 1.4 (95% CI
1.0-2.1) (Table 5).
Seven hundred and twenty participants reported hav-
ing chronic gastritis. Compared with those without, sub-
jects with chronic gastritis have an unadjusted OR of 8.5
(95% CI 6.1-11.8) to report GERD symptom. This rela-
tion remained stable after further adjustment for all cov-
ariates, with an OR of 8.2 (95% CI 5.8-11.5) (Table 5).
Similarly, retirees who had a history of peptic ulcer
tended to be more prone to report the reflux symptoms,
with an unadjusted OR of 5.1 (95% CI 3.0-8.7), and the
association remained strong after multivariable-adjust-
ment, with an OR of 3.3 (95% CI 1.8-6.1) (Table 5).
High serum TG (≥1.81mmol/l) was significantly asso-
ciated with the presence of GERD (OR: 2.0; 95% CI: 1.3-
3.3). This relation remained stable after further adjustment
for all covariates, with an OR of 2.0 (95% CI 1.2-3.4)
(Table 5).
Discussion
This population-based study on the epidemiology of
GERD surveyed a total of 8867 retired individuals in
China. The overall prevalence of GERD in the present
study was 1.7% which was lower than that in previous
Chinese population-based surveys using a variety of defi-
nitions of GERD. A possible explanation for this differ-
ence is that the participants in this study were all
retirees who did not have much psychological stress.
The occurrence and response to treatment of GERD
were reported to be associated with stress [23]. In
addition, the study subjects in several previous studies
Table 2 Severity, use of medication, and frequency of symptoms among subjects with at least once per week
gastroesophageal reflux episode
Frequency of the gastroesophageal reflux symptoms Total
(%)Once per week (%) Several times per week (%) Daily (%)
Severitya
Negligible or Mild 65 (90.2) 49 (89.1) 16 (69.6) 130 (86.7)
Moderate 2 (2.8) 1 (1.8) 2 (8.7) 5 (3.3)
Severe 2 (2.8) 1 (1.8) 1 (4.3) 4 (2.7)
Very severe 3 (4.2) 4 (7.3) 4 (17.4) 11 (7.3)
Medication use
None 50 (69.4) 36 (65.4) 10 (43.5) 96 (64.0)
H2Ra 17 (23.6) 14 (25.5) 9 (39.1) 40 (26.7)
PPI 4 (5.6) 4 (7.3) 4 (17.4) 12 (8.0)
Other anti-acid medication 1 (1.4) 1 (1.8) 0 (0.0) 2 (1.3)
H2Ra: H2-receptor antagonist; PPI: proton pump inhibitors.
aMild: almost can be ignored; Moderate: cannot be ignored but can be tolerated; Severe: affects normal daily life; Very severe: markedly, affects normal daily life.
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ters or those who attended health screening. It is well
known that subjects with gastrointestinal symptoms are
more likely to go for this kind of examination.
A clear association between GERD and obesity has
been found in Western countries [6,9]. But we did not
find an association between obesity and GERD. Previous
population-based studies on the association between
GERD and BMI in China have also reported inconsistent
results [16,24]. In this study, we assessed the association
between GERD and abdominal obesity (indicated by
waist circumference and waist-to-hip ratio), but the
results did not show any significant association between
central obesity and the reflux symptoms. This could po-
tentially be explained by relatively low prevalence of
obesity in China.Table 3 Obesity related factors and risk of symptomatic gastr
Variables Cases Controls Unadjusted
BMI (kg/m2)
<24.0 66 3363 1.0
24.0-27.9 65 3251 1.0
≥28.0 19 1287 0.8
Waistb (cm)
Low 116 6021 1.0
High 34 1879 0.9
WHRc
Low 106 5915 1.0
High 44 1985 1.2
BMI: body mass index (weight[kg]/height2[m]); WHR: wasit-to-hip ratio; OR, odds rat
aIn the multivariate logistic regression model adjustments were made for age, sex,
of diabetes mellitus, hypertension, gastritis or peptic ulcer, and serum TG.
bLow: Male<92cm and female<88cm; High: Male≥92cm and female≥88cm.
cLow: Male<0.95 and female<0.89; High: Male≥0.95 and female≥0.89.In the current study, we found an association between
diabetes mellitus and GERD. This is consistent with the
previous studies performed in Japan [13] and Korea
[25,26]. A Korean study reported that about 23.1% of the
patients with type II diabetes experienced at least weekly
typical GERD symptoms [25]. Another study showed
that the prevalence of GERD symptoms in diabetes
patients was 41% [14], which was higher than the
reported prevalence in the general population. There are
several possible mechanisms underlying diabetes-related
GERD. Some studies have shown that many gastrointes-
tinal symptoms in diabetes patients are linked to motor
dysfunction and that the neuropathy in diabetes patients
may play an important role on the development of
GERD symptoms. Autonomic nervous disorder in dia-
betes patients might cause a certain degree of gastricoesophageal reflux








io; CI, confidence interval.
education, occupation, tobacco smoking, alcohol drinking, tea drinking, history
Table 4 Lifestyle related factors and risk of symptomatic gastroesophageal reflux
Variables Cases Controls Unadjusted OR 95% CI Adjusted ORa 95% CI
Smoking
Never 108 5739 1.0 (ref) 1.0 (ref)
Ex-smokers 16 559 1.5 (0.9-2.6) 1.5 (0.8-3.1)
Current smokers 26 1597 0.9 (0.6-1.3) 0.9 (0.5-1.6)
Alcohol drinking
Never 129 6713 1.0 (ref) 1.0 (ref)
Regular 21 1188 0.9 (0.6-1.5) 1.2 (0.7-2.1)
Tea drinking
No 120 5985 1.0 (ref) 1.0 (ref)
Yes 30 1914 0.8 (0.5-1.2) 0.8 (0.5-1.3)
OR, odds ratio; CI, confidence interval.
aORs were mutually adjusted for variables listed in the table, as well as age, sex, waist-to-hip ratio, history of diabetes mellitus, hypertension, gastritis, or peptic
ulcer, and serum TG.
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and lead to a higher incidence of transient lower esopha-
geal sphincter relaxation [25].
Among the individual components of metabolic syn-
drome, an elevated level of serum TG was a significant
predictive factor for the GERD. This result is consistent
with previous studies about metabolic syndrome and
GERD or erosive esophagitis [12,27,28]; however, a Japa-
nese study did not find such an association between ele-
vated serum TG and erosive esophagitis [13]. It has been
reported that hypertriglyceridemia is associated with
increased insulin resistance [29] and chronic Helicobac-
ter pylori infections which was suggested to be a protect-
ive factor for erosive esophagitis can modify the serum
lipid profile [30,31]. Therefore, elevated serum TG levelsTable 5 Past history of diseases and risk of symptomatic gast
Variables Cases Controls Unadjusted
Diabetes Mellitus
No 122 7134 1.0
Yes 28 766 2.1
Hypertension
No 84 5067 1.0
Yes 66 2831 1.4
Gastritis
No 85 7240 1.0
Yes 65 655 8.5
Peptic ulcer
No 134 7719 1.0
Yes 16 181 5.1
Serum TG
<1.81mmol/L 131 7378 1.0
≥1.81mmol/L 19 523 2.0
OR, odds ratio; CI, confidence interval.
aORs were mutually adjusted for variables listed in the table, as well as age, sex, wamay be just an epiphenomenon accompanying other
etiologic factors.
Hypertension was found, after adjusting for BMI, to be
associated with GERD. In a Japanese study, hypertension
and hyperglycaemia were independent risk factors for ero-
sive esophagitis [13]. In a Korean population, the presence
of metabolic syndrome and a higher visceral adipose tissue
area were suggested as risk factors for esophagitis [27].
Consistent with the above, we found hypertension was a
risk factor for symptom-defined GERD, but we did not in-
vestigate drug therapy of the participants in the present
study. Calcium antagonists used to treat hypertension de-
crease the lower esophageal sphincter pressure and inhibit
muscle contraction in the esophagus itself [32]. In China,
calcium antagonists are widely used to treat hypertension,roesophageal reflux











ist-to-hip ratio, tobacco smoking, alcohol drinking, and tea drinking.
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plain the findings in our study.
The current study supports an association of GERD
with a history of peptic ulcer disease and gastritis. A
large population-based study on the epidemiology of
GERD across five regions in China also reported an as-
sociation between GERD and peptic ulcer and gastritis
[16]. In contrast, a study performed in Finland found a
protective effect for gastritis against GERD [15]. How-
ever, it is important to distinguish between clinically
diagnosed gastritis and the patient-reported history of
gastritis which was used in the current study. In China,
“gastritis” generally indicates upper gastrointestinal dis-
comfort and a diagnosis is unlikely to be based on endo-
scopic examination biopsy or serum pepsinogen
measurement. The major limitation of our study is that
the medical history of participants was self-reported is
the biggest limitation of our study, but it should be
noted that it is a standard practice in China for patients
to keep their own medical records which, in some ex-
tent, may reduce the impact of this limitation.
Conclusion
This study showed the prevalence of GERD in this re-
tiree cohort is lower than that in Western populations,
and its occurrence is independent of obesity or abdom-
inal obesity. However, elevated level of serum TG, a
medical history of hypertension, diabetes, peptic ulcer
disease and gastritis are associated with an increased risk
of developing GERD in this population. Further studies
are needed to more fully elucidate potential mechanisms
underlying these relationships.
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